Montmorency Cherry Juice and Uric Acid Metabolism
Клучни зборови
Апстракт
Опис
Plasma and urinary uric acid concentration, plasma phytochemical content and inflammatory biomarkers will be measured in order to elucidate the effects of an acute dose of tart cherry juice on indices related to the condition of gout.
Participants will be required to attend the laboratory at a range of time points over two periods of 96 hours, separated by a 7 day washout period, to provide blood samples. In order to provide a baseline sample, participants will attend the laboratory in the morning following an overnight fast and voiding of any urine. Following this participants will be given 30mls (30 mls provides 323 mg/380 µmol of anthocyanins) of tart cherry juice or placebo, diluted with 60 mls of water to consume within 10 minutes. Participants will be required to consume identical dosages of the supplement immediately prior to evening meals and breakfasts (or same time each morning following blood sampling if non-breakfast eater) over the next 96 hours. Further blood and urine samples will be collected at 1, 2, 3, 5, 8, 24, 26, 48, 50, 72, 74 and 96 hours and will require participants to return to the laboratory at each of these time points. Following the first period of supplementation participants will complete a 7 day washout period in which they will not be required to attend the laboratory. Following the washout period they will repeat the supplementation period consuming the supplement they did not receive during the first period.
Датуми
Последен пат проверено: | 03/31/2013 |
Прво доставено: | 03/28/2013 |
Поднесено е проценето запишување: | 04/01/2013 |
Прво објавено: | 04/04/2013 |
Последното ажурирање е доставено: | 04/01/2013 |
Последно ажурирање објавено: | 04/04/2013 |
Крај на датумот на започнување на студијата: | 02/29/2012 |
Проценет датум на примарно завршување: | 06/30/2012 |
Проценет датум на завршување на студијата: | 02/28/2013 |
Состојба или болест
Интервенција / третман
Dietary Supplement: Montmorency cherry concentrate
Фаза
Групи за раце
Рака | Интервенција / третман |
---|---|
Experimental: low dose Montmorency cherry concentrate, 30 mls | |
Experimental: higher dose Montmorency cherry concentrate, 60 mls |
Критериуми за подобност
Возраст подобни за студии | 18 Years До 18 Years |
Полови квалификувани за студии | All |
Прифаќа здрави волонтери | Да |
Критериуми | Inclusion Criteria: - apparently healthy males/females between the ages of 18-40 years Exclusion Criteria: - underlying clinical pathology |
Исход
Мерки на примарниот исход
1. Change in uric acid [0, 1, 2, 3, 5, 8, 24, 26, 48 hours]
Секундарни мерки на исходот
1. Change in C-reactive protein [0,1,2,3,5,8,24,26,48 hours]
Други мерки на исход
1. Change in anthocyanins, polyphenolics and creatinine [0,1,2,3,5,8,24,26,48 hours]